María Fernanda González-Lara

Author

Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán ORCID

Also Known As

MF González-Lara, Maria F Gonzalez-Lara, Maria F. Gonzalez-Lara, Maria F. Gonzalez‐Lara, Maria F. González-Lara, Maria Fernanda Gonzalez-Lara, Maria Fernanda González-Lara, María F Gonzalez-Lara, María F González Lara, María F González-Lara

Publications

2.6K

Citations

H-Index

Concepts

All Affiliations

Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán Universidad Nacional Autónoma de México Instituto Nacional de Pediatria The University of Texas Health Science Center at Houston Elmhurst Hospital Center

About

María Fernanda González-Lara is an author at Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán specializing in medicine, infection control, and covid-19.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	63
2	Public Health	1	1	19
3	Blood Transplantation	1	1	19
4	Cellular Therapies	1	1	19
5	Emergency Medicine	1	1	25

María Fernanda González-Lara

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia Carlos Salama, Jian Han, Linda Yau, New England Journal of Medicine	2020	1.3K
In-hospital mortality from severe COVID-19 in a tertiary care center in Mexico City; causes of death, risk factors and the impact of hospital saturation Antonio Olivas‐Martínez, José Luis Cárdenas-Fragoso, José Víctor Jiménez, PLoS ONE	2021	146
Clinical and Epidemiological Characteristics of Patients Diagnosed with COVID-19 in a Tertiary Care Center in Mexico City: A Prospective Cohort Study Edgar Ortíz‐Brizuela, Marco Villanueva-Reza, María Fernanda González-Lara, Revista de investigaci�n Cl�nica	2020	106
Impact of undiagnosed type 2 diabetes and pre-diabetes on severity and mortality for SARS-CoV-2 infection Arsenio Vargas‐Vázquez, Omar Yaxmehen Bello‐Chavolla, Edgar Ortíz‐Brizuela, BMJ Open Diabetes Research & Care	2021	60
Accuracy of galactomannan testing on tracheal aspirates in COVID‐19‐associated pulmonary aspergillosis Carla M. Román‐Montes, Areli Martínez‐Gamboa, Paulette Diaz‐Lomelí, Mycoses	2020	57
Antimicrobial Resistance Patterns and Antibiotic Use during Hospital Conversion in the COVID-19 Pandemic Bernardo Alfonso Martínez-Guerra, María Fernanda González-Lara, Nereyda A. de-León-Cividanes, Antibiotics	2021	57
Substantial reduction of healthcare facility-onset Clostridioides difficile infection (HO-CDI) rates after conversion of a hospital for exclusive treatment of COVID-19 patients Eric Ochoa‐Hein, Sandra Rajme‐López, Juan Carlos Rodríguez‐Aldama, American Journal of Infection Control	2020	44
Low Thoracic Skeletal Muscle Area Is Not Associated With Negative Outcomes in Patients With COVID-19 Paulina Moctezuma‐Velázquez, Godolfino Miranda-Zazueta, Edgar Ortíz‐Brizuela, American Journal of Physical Medicine & Rehabilitation	2021	44
Early Outpatient Treatment With Remdesivir in Patients at High Risk for Severe COVID-19: A Prospective Cohort Study Sandra Rajme‐López, Bernardo Alfonso Martínez-Guerra, Jessica Zalapa‐Soto, Open Forum Infectious Diseases	2022	42
Validation and repurposing of the MSL-COVID-19 score for prediction of severe COVID-19 using simple clinical predictors in a triage setting: The Nutri-CoV score Omar Yaxmehen Bello‐Chavolla, Neftalí Eduardo Antonio-Villa, Edgar Ortíz‐Brizuela, PLoS ONE	2020	28

Page 1